Analysis of Down syndrome failed to be diagnosed after prenatal screening A multicenter study

被引:7
|
作者
Jiang, Tao [1 ]
Ding, Jie [2 ]
Zhang, Xiao-Qing [3 ]
Zhang, Xiao-Juan [1 ]
Zhang, Bin [3 ]
Wang, Ting [2 ]
Yu, Bin [3 ]
机构
[1] Nanjing Med Univ, Obstet & Gynecol Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Suzhou Municipal Hosp, Suzhou 215000, Peoples R China
[3] Nanjing Med Univ, Changzhou Woman & Children Hlth Hosp, Changzhou 213003, Jiangsu, Peoples R China
关键词
biomarkers; Down syndrome; missed diagnosis; prenatal diagnosis; prenatal screening; serum; FREE BETA-HCG; 2ND TRIMESTER; ALPHA-FETOPROTEIN;
D O I
10.1097/MD.0000000000007166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To analyze the characters of Down syndrome (DS) who failed to be diagnosed after prenatal screening and hope to be able to improve the programs of prenatal screening and reduce the missed diagnosis of DS. In this multicenter study, we collected the missed cases from 3 prenatal diagnosis centers and analyzed their characters. A total of 126 DS babies failed to be diagnosed after prenatal screening. Their mothers accepted the prenatal screening in second trimester. We collected the mothers' blood and detected the levels of alpha-fetoprotein (AFP) and the free beta subunit of human chorionic gonadotropin (f beta hCG) by time-resolved fluoroimmunoassay. The values were also presented as multiples of the median (MoM) and determined the risk of carrying a fetus with DS by Wallace LifeCycle Elipse analysis software. Compared with normal control group, the level of fbhCG and hCG MoM were dramatically increased, while AFP and AFP MoM were decreased. The area under the receiver-operating-characteristic curve of trisomy 21 was 0.8387 for hCG-MoM and AFP-MoM testing. The sensitivity, specificity, positive predictive value, and negative predictive value were 84.6%, 74.8%, 75.4%, and 83.6%, respectively. Meanwhile, the prediction mode was '' 0.39957+1.90897(*) HCG-MOM -3.32713(*) AFP-MOM". It was worthwhile noting that the risk of 65.9% DS missed diagnosis group were higher than 1/1000, 92.9% higher than 1/3000. However, 72.5% cases in normal control group were lower than 1/3000. Only 9.2% mothers would be higher than the value of risk in 1/1000. The prediction mode of hCG MoM and AFP MoM might be able to help us reduce the missed diagnosis. It is also necessary to adjust more reasonable range of noninvasive prenatal testing with further clinical researches.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Accuracy of Down's syndrome risks produced in a prenatal screening program
    Spencer, K
    ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 : 101 - 103
  • [22] Providing information about prenatal screening for Down syndrome: a systematic review
    Skjoth, Mette M.
    Draborg, Eva
    Pedersen, Claus D.
    Hansen, Helle P.
    Lamont, Ronald F.
    Jorgensen, Jan S.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2015, 94 (02) : 125 - 132
  • [23] Prenatal screening of Down syndrome: elaboration of an information document for pregnant women
    Flori, Marie
    Lamort-Bouche, Marion
    Perdrix, Corinne
    Laville, Agnes
    Silve, Laure
    de Miscault, Jeanne
    Goffette, Jerome
    Zerbib, Yves
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2016, 27 (125): : 100 - 105
  • [24] Information about prenatal screening for Down syndrome Ethnic differences in knowledge
    Fransen, Mirjam P.
    Wildschut, Hajo
    Vogel, Ineke
    Mackenbach, Johan
    Steegers, Eric
    Essink-Bot, Marie-Louise
    PATIENT EDUCATION AND COUNSELING, 2009, 77 (02) : 279 - 288
  • [25] Cross-trimester marker ratios in prenatal screening for Down syndrome
    Wald, Nicholas J.
    Bestwick, Jonathan P.
    Morris, Joan K.
    PRENATAL DIAGNOSIS, 2006, 26 (06) : 514 - 523
  • [26] Prenatal screening for Down syndrome and neural tube defects in twin pregnancies
    Wald, NJ
    Rish, S
    PRENATAL DIAGNOSIS, 2005, 25 (09) : 740 - 745
  • [27] Prospective prenatal serum screening for Down syndrome in Venezuela
    Alvarez-Nava, Francisco
    Sotop, Marisol
    Morales-Machin, Alisandra
    Rojas, Alicia
    Urdaneta, Karelis
    Canizalez, Jenny
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 103 (03) : 241 - 245
  • [28] Comparison of Current Methods of Prenatal Screening for Down Syndrome
    Hoermansdoerfer, Cindy
    Corral, Alejandro
    Scharf, Alexander
    Vaske, Bernhard
    Hillemanns, Peter
    Schmidt, Peter
    REVISTA ESPANOLA DE SALUD PUBLICA, 2010, 84 (01): : 43 - 51
  • [29] Determinants of parental decisions after the prenatal diagnosis of Down syndrome
    Kramer, RL
    Jarve, RK
    Yaron, Y
    Johnson, MP
    Lampinen, J
    Kasperski, SB
    Evans, MI
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 79 (03): : 172 - 174
  • [30] Analysis of External Quality Assessment of Maternal Serum Prenatal Screening for Down Syndrome in the First Trimester in China
    He, Falin
    Wang, Wei
    Zhong, Kun
    Yuan, Shuai
    Du, Yuxuan
    Wang, Zhiguo
    CLINICAL LABORATORY, 2021, 67 (06) : 1357 - 1364